Technology ID
TT-0109
Description
In the battle against Alzheimer’s disease, early detection is key to effective intervention. Our cutting-edge diagnostic system employs proteomics and advanced machine learning to identify early-stage Alzheimer’s before clinical symptoms manifest. By analyzing subtle changes in blood biomarkers, our technology not only detects the disease early but also monitors its progression and response to treatment, enabling timely and personalized therapeutic strategies.
Content
Early and Accurate Detection: Capable of identifying Alzheimer’s years before symptoms with 96% accuracy, assisting clinicians in timely disease management
Disease Co-Pathologies Monitoring: Tracks co-pathologies of Alzheimer’s through multi-protein approach, facilitating assessment of disease progression
Screening Tool: Serves as an invaluable population screening solution from early ages, facilitating large-scale access in rural regions
Inventors
Applicable Industries
Potential Application
Technology Focus
TRL
Images
